Making medicine more precise for patients with leukaemia and lymphoma
Posted on 24 September 2014
Patients with leukaemia and lymphoma differ greatly in their response to current treatments. The aim of precision medicine is target treatment based on knowledge of the specific characteristics of the tumour cells. Advances in diagnostic technologies and the availability of many new drugs is at last making this a goal that may be realized in the near future.
Professor Andrew Jack will talk about making medicine more precise for patients with leukaemia and lymphoma. Admission is by free ticket only. To book a place visit www.york.ac.uk/news-and-events/events/public-lectures/autumn-2014/medicine-precise/.
Tea/coffee available from 5.30pm.